We're here for you during the COVID-19 outbreak. Click here for resources.
GAMMAGARD LIQUID is indicated as replacement therapy for primary humoral immunodeficiency (PI) in adult and pediatric patients ≥2 years.
Fill out and submit the Gammagard Liquid Start Form to initiate treatment for your patients.
You are being directed to another website.Return to HCP Site Continue
The information on this website is technical in nature, and has been specifically created for healthcare professionals. If you are not a healthcare professional and would like to visit the consumer site, please visit www.GAMMAGARD.com.
The people we serve are our highest priority.
We are here as you navigate challenges during the COVID-19 outbreak. Stay updated on COVID-19
For questions about financial assistance, navigating health insurance, or administration training, please reach out to OnePath support. Get answers from OnePath Support